As of August 6, 2021, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the virus responsible for the coronavirus disease 2019 (COVID-19), has infected over 201 million people and caused the deaths of almost 4.3 million worldwide.
The high transmissibility and unpredictable nature of SARS-CoV-2 has supported the rapid development of several COVID-19 vaccines that have already been distributed in many countries around the world. To date, almost 30% of the world’s population has received at least one dose of a COVID-19 vaccine.
The recent rise in COVID-19 cases
The rise in SARS-CoV-2 cases in Israel, as well as many other countries around the world, requires a better understanding of how SARS-CoV-2 immune protection can weaken over time in both vaccination individuals and those who are convalesced seropositive as a result of previous SARS-CoV-2 infection. To this end, a recent study published on the preprint server medRxiv* determines whether the time elapsed since the second dose of the BNT162b2 vaccine is associated with an increased risk of breakthrough SARS-CoV-2 infection.
About the study
The current study is a retrospective cohort study that is based on data collected from the Leumit Health Services (LHS), which is a large healthcare provider in Israel. The cohort included 33,993 individuals who had received a reverse transcriptase polymerase chain reaction (RT-PCR) test between May 15, 2021, and July 26, 2021, at least two weeks after receiving their second dose of the COVID-19 vaccine.
To reflect the vaccine rollout stages, the researchers included three age groups in the study, which included individuals who were 60 or older, between the ages of 40 and 59, and between the ages of 18 and 39. Importantly, at the time of their RT-PCR test, none of the study participants had any evidence of previous COVID-19 infection.
Study results
The median time between when the participants had received the second dose of the COVID-19 vaccine and received an RT-PCR test was 146 days. However, over 50% of the participants had received an RT-PCR test over 146 days since their second dose.
Using 146 days as their cut-off, the researchers found that within the 60 and over age group, 2.19% of vaccinated individuals tested positive for SARS-CoV-2. Comparably, the positivity rate in the 40-59 and 18-39 age groups was 1.93% and 1.39%, respectively. Taken together, the increase in SARS-CoV-2 infection rates across all patient populations was significant.
Notably, at the time when the study was conducted, the dominant circulating variant was the SARS-CoV-2 Delta variant B.1.617.2. Of the 113 isolates that were sent for sequencing in this study, 93% tested positive for the Delta variant.
News
Largest-Ever Physics Survey Raises New Doubts About Our Model of the Universe
Physicists around the world remain deeply divided on key mysteries of the universe, from dark matter to quantum gravity. The standard cosmological model failed to gain majority support, and no leading theory dominated the [...]
Scientists Just Overturned a 100-Year-Old Belief About Bacteria in the Lungs
New findings raise questions about the role of microbes living in the lungs. More than 35 trillion bacteria live throughout the human body, forming microbiomes in the gut, mouth, lungs, skin, and urogenital tract. [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
Is there a summer COVID-19 surge this year? Yep, it’s ramping up again
Hantavirus. Ebola. West Nile. Measles. And, of course, cyclospora — that stomach parasite making people miserable across the country. Americans have plenty to worry about this summer. But remember COVID-19? It may not be [...]
